Sponsor Dossier
Dr Falk Pharma
Sponsor Dossier for Dr Falk Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: BUDENOFALK
- Brand: JORVEZA
- Brand: SALOFALK
- Brand: URSO
- Brand: URSOFALK
- Device (sponsor): Applicator, <specify>
About
Dr Falk Pharma is an Australian Private Company with ABN 40631091131, registered in New South Wales. The company is Active on the Australian Business Register.
Portfolio
Dr Falk Pharma has 5 brands on the ARTG, of which 5 are indexable and 5 carry a Product Information document. 4 brands are PBS-listed, 4 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include BUDENOFALK, JORVEZA, SALOFALK, URSO, URSOFALK.
Therapeutic focus
— Gastroenterology: 3 brands — Hepatology: 2 brands
PBS footprint
4 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2024-11-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2012-11-15, across 1 brand with an AusPAR on record.